BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3392656)

  • 61. Rhythmical slow wave electroencephalographic activity elicited by hippocampal injection of muscarinic agents in the rat.
    Malisch R; Ott T
    Neurosci Lett; 1982 Jan; 28(1):113-8. PubMed ID: 7063141
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Changes in muscarinic acetylcholine receptors of mice by chronic administrations of diisopropylfluorophosphate and papaverine.
    Uchida S; Takeyasu K; Matsuda T; Yoshida H
    Life Sci; 1979 May; 24(19):1805-12. PubMed ID: 459683
    [No Abstract]   [Full Text] [Related]  

  • 63. Cross-tolerance between muscarinic agonists: role of muscarinic receptors.
    Collins AC; Smolen TN; Smolen A; Medhurst LJ
    Pharmacol Biochem Behav; 1987 Jan; 26(1):173-82. PubMed ID: 3562489
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of oxotremorine on synthesis of acetylcholine in striatum and whole brain of mice killed by various techniques.
    Karlèn B; Lundgren G; Lundin J; Holmstedt B
    Life Sci; 1977 May; 20(10):1651-5. PubMed ID: 875610
    [No Abstract]   [Full Text] [Related]  

  • 65. Increased agonist affinity is induced in tetranitromethane-modified muscarinic receptors.
    Gurwitz D; Sokolovsky M
    Biochemistry; 1985 Dec; 24(27):8086-93. PubMed ID: 4092058
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regulation of the subcellular distribution of m4 muscarinic acetylcholine receptors in striatal neurons in vivo by the cholinergic environment: evidence for regulation of cell surface receptors by endogenous and exogenous stimulation.
    Bernard V; Levey AI; Bloch B
    J Neurosci; 1999 Dec; 19(23):10237-49. PubMed ID: 10575021
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Proceedings: On the action of oxotremorine on the cholinergic system of rat brain.
    Pleul O
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R75. PubMed ID: 4276628
    [No Abstract]   [Full Text] [Related]  

  • 68. Spontaneous regeneration of free muscarinic receptor after alkylation by BM 123. I. Recovery in vivo and in cell culture.
    Waite JJ; Jenden DJ
    J Pharmacol Exp Ther; 1989 Jan; 248(1):111-8. PubMed ID: 2913265
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of oxotremorine demonstrate presynaptic muscarinic and dopaminergic receptors on motor nerve terminals.
    Ganguly DK; Das M
    Nature; 1979 Apr; 278(5705):645-6. PubMed ID: 450064
    [No Abstract]   [Full Text] [Related]  

  • 70. Role of muscarinic cholinergic receptors in the control of the intensity of nonquantal acetylcholine release from rat motor nerve endings.
    Malomouzh AI; Mukhtarov MR; Nikolsky EE
    Dokl Biol Sci; 2007; 414():180-2. PubMed ID: 17668614
    [No Abstract]   [Full Text] [Related]  

  • 71. Inhibitory cholinergic effects on the autonomously contractile bulbus cordis branchialis of the cephalopod Sepia officinalis L.
    Gebauer M; Versen B; Schipp R
    Gen Pharmacol; 1999 Jul; 33(1):59-66. PubMed ID: 10428017
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Regional brain metabolic responsivity to the muscarinic cholinergic agonist arecoline is similar in young and aged Fischer-344 rats.
    Soncrant TT; Holloway HW; Greig NH; Rapoport SI
    Brain Res; 1989 May; 487(2):255-66. PubMed ID: 2731046
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Spontaneous regeneration of free muscarinic receptor after alkylation by BM 123. II. Recovery in broken cell preparations.
    Waite JJ; Jenden DJ
    J Pharmacol Exp Ther; 1989 Jan; 248(1):119-26. PubMed ID: 2913266
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Discriminative stimulus properties of arecoline: a new approach for studying central muscarinic receptors.
    Meltzer LT; Rosecrans JA
    Psychopharmacology (Berl); 1981; 75(4):383-7. PubMed ID: 6803285
    [TBL] [Abstract][Full Text] [Related]  

  • 75. On the interaction of drugs with the cholinergic nervous system--IV. Tolerance to oxotremorine in mice: in vivo and in vitro studies.
    Maayani S; Egozi Y; Pinchasi I; Sokolovsky M
    Biochem Pharmacol; 1977 Sep; 26(18):1681-7. PubMed ID: 901587
    [No Abstract]   [Full Text] [Related]  

  • 76. Brain GABA, dopamine and acetylcholine interactions. 1. Studies with oxotremorine.
    Pérez de la Mora M; Fuxe K
    Brain Res; 1977 Oct; 135(1):107-22. PubMed ID: 912426
    [No Abstract]   [Full Text] [Related]  

  • 77. Action of a chronic arecoline administration on mouse motility and on acetylcholine concentrations in the CNS.
    Molinengo L; Fundaró AM; Cassone MC
    J Pharm Pharmacol; 1988 Nov; 40(11):821-2. PubMed ID: 2907570
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of oxotremorine on the acetylcholine content of whole brain and various brain regions in the pigeon.
    Igić R
    Br J Pharmacol; 1971 Jun; 42(2):303-4. PubMed ID: 5091163
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The central and peripheral effectiveness of two oxotremorine-antagonists determined using oxotremorine-induced tremor and salivation.
    Eicholzer A; Ogren SO
    J Pharm Pharmacol; 1977 Oct; 29(10):609-11. PubMed ID: 21240
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Time-related effects of stress on cholinergic sensitivity.
    Pullia D; D'Amato FR; Mele A; Oliverio A; Zocchi A; Pavone F
    Brain Res; 1996 Dec; 743(1-2):333-6. PubMed ID: 9017264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.